Home > Insider Trading > Filing (0000902664-12-001567)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1013238	Aradigm Corp	ARDM	Electromedical & Electrotherapeutic Apparatus (3845)	943133088

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
754094	Ltd. Associates Def	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No
1325447	First Eagle Investment Management, Llc	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No
1457518	First Eagle Value In Biotechnology Master Fund, Ltd.	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No
1459688	21 April Fund Lp	1345 Avenue Of The Americas, 44Th Floor New York NY 10105	No	No	Yes	No
1459708	Ltd Fund April 21	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No
1506964	Def Associates Lp	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value (The "Common Stock")	Acquisiton	2012-12-11	41,666,667	$0.12	114,004,319	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Footnotes

The shares of Common Stock to which this relates are held directly by First Eagle Value in Biotechnology Master Fund, Ltd., a Cayman Islands exempted company ("FEVIB"), 21 April Fund, Ltd., a Cayman Islands exempted company ("April LTD"), 21 April Fund, L.P., a Delaware limited partnership ("April LP"), DEF Associates, LP, a Delaware limited partnership ("DEF LP"), DEF Associates, Ltd., a British Virgin Islands corporation ("DEF LTD" and together with FEVIB, April LTD, April LP and DEF LP, the "Funds"), and certain managed accounts (collectively, the "Accounts").
The shares of Common Stock reported herein are indirectly beneficially owned by First Eagle Investment Management, LLC, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940 ("FEIM"), by virtue of its service as investment manager to the Funds and Accounts, which are under FEIM's management and control. Each of the reporting persons disclaims beneficial ownership of the securities to which this Form 4 relates for the purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of the reporting person's pecuniary interest in the securities.